Journal article
IND.210: A randomized phase 2 trial of FOLFOX6/bevacizumab with or without reovirus (Reo) in patients (pts) with metastatic colorectal cancer (mCRC).
Authors
Tang PA; Jonker DJ; Kennecke HF; Welch S; Cripps MC; Asmis TR; Chalchal HI; Tomiak AT; Ko Y-J; Chen E
Journal
Journal of Clinical Oncology, Vol. 34, No. 15_suppl, pp. 3546–3546
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2016
DOI
10.1200/jco.2016.34.15_suppl.3546
ISSN
0732-183X